Lead author Thomas Churilla, a medical student at the Commonwealth Medical College, Scranton, Pa., said the study involved 160 patients with a median age of 64 -- half women, half men. The five most common primary diagnoses were breast, prostate, lung, thyroid and colorectal cancer.
The study found 77 percent of the patients had vitamin D concentrations either deficient -- less than 20 nanograms per milliliter, or sub-optimal 20 to 30 ng/mL.
The median serum vitamin D level was 23.5 ng/mL, but regardless of the age or sex of the patient, levels of vitamin D were below the median predicted for advanced stage disease in the patient group.
Patients found to be vitamin D deficient were administered replacement therapy, increasing serum D levels by an average of 14.9 ng/mL.
"The benefits of vitamin D outside of improving bone health are controversial, yet there are various levels of evidence to support that vitamin D has a role in either the prevention or the prediction of outcome of cancer," Churilla said in a statement.
The findings were presented at the 53rd annual meeting of the American Society for Radiation Oncology in Miami.
Exploding whale video goes viral on Internet
Reindeer recovered after escaping from Santa during lighting ceremony